• Infinitum Health Team

Fucoidan (from seaweed) as potential inhibitor of Corona, HIV-1, Herpes, and other envelope viruses?

Updated: Apr 19

Dramatic research showing broad spectrum antiviral properties, yet again, with the power of seaweed and its key extract, fucoidan, already available in our Infinimin® Multivitamin.

More research is needed, but numerous studies speak about the incredibly deadly Human Immuno-deficiency Virus (HIV-1), Herpes Simplex Virus (HSV), Coronavirus, and other "enveloped" and "non enveloped" viruses being prohibited from binding to a host - i.e. PREVENTION from viruses!!!

They speak to fucoidan's ability to inhibit the actual binding of enveloped viruses, specifically, HIV-1, HSV, and Coronavirus. According to the research, " ... all natural fucoidans can be considered as potential anti-HIV agents, like having a detergent for your body ... ".

Even more amazing, these studies speak of a few of our key seaweed species in our Infinimin® Multivitamin, saccharina japonica (also know as laminaria japonica), undaria pinnatifida (also known as wakame), and fucus vesiculosous (also known as bladderwrack, having the most potent broad spectrum antiviral activity!

Many authors conclude the research by stating similar summaries such as, "The investigated fucoidans suppressed transduction of particles that contain envelope protein needed for virus binding, regardless to structure of carbohydrate backbone." It prohibits binding, altogether.

Additional authors state, "Herpes (HSV) could be considered a preventable virus if more seaweed supplementation was promoted in population health systems."

Finally, "broad pandemic level viruses such as Avian Flu, SARs, and Coronavirus could be completely prevented if more seaweed supplementation occurred in populations lacking these key nutritional compounds like Fucoidan"

While more research is still needed, fantastic summary of research provided by multiple sources to aid us in our ever evolving pursuit of "health, forever, without limits (sm)"

To your health,

~Infinitum Health Team


1. Prokofjeva, et al. "Fucoidan as potential inhibitors of HIV-1". Marine Drugs, August 2013.

2. Elumalai Sanniyasi et. al. "In vitro anti-HIV-1 activity of the bioactive compound extracted and purifed from two diferent marine macroalgae (seaweeds)". Nature, April 2019.

3. N. N. Besednova, et. al. "Antiviral Activity and Pathogenetic Targets for Seaweed Sulfated Polysaccharides in Herpesvirus Infections." Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry, 2016, Vol. 10, No. 1, pp. 31–42.

4. UNAIDS. Fact sheet –World AIDS Day 2018. 2030. Ending the AIDS Epidemic. 1–6 (2017).

5. Artan, M., Karadeniz, F., Karagozlu, M. Z., Kim, M.-M. & Kim, S.-K. Anti-HIV activity of low molecular weight sulfated chitooligosacharides. Carbohydrate Research. 345(5), 656–662 (2010).

6. Hamzah, L. et al. Treatment‐limiting renal tubulopathy in patients treated with tenofovir disoproxil fumarate. J. Infect. 74(5), 492–500 (2017).

7. Suzuki, S. et al. Efect of tenofovir disoproxil fumarate on incidence of chronic kidney disease and rate of estimated glomerular fltration rate decrement in HIV‐1‐infected treatment‐naïve Asian patients: results from 12‐year observational cohort. AIDS Patient Care STDS. 31(3), 105–112 (2017).

8. Tanuma, J. et al. Renal dysfunction during tenofovir use in a regional cohort of HIV‐infected individuals in the Asia‐Pacifc. PLoS One. 11(8), e0161562 (2016).

9. Zuniga, M. et al. Tenofovir‐associated Fanconi’s syndrome and rickets in a HIV infected girl. Rev. Chil. Pediatr. 88(1), 148–152 (2017).

10. Joshi, K. et al. Changes in renal function with long‐term exposure to antiretroviral therapy in HIV‐infected adults in Asia. Pharmacoepidemiol Drug Saf. 27(11), 1209–1216 (2018).

11. Liu, J. et al. Population -based human immunodefciency virus 1 drug resistance profles among individuals who experienced virological failure to first-line antiretroviral therapy in Henan, China during 2010–2011. AIDS Res. Ther. 12, 22, https://doi. org/10.1186/s12981-015-0062-y (2015).

12. Gregson, J., Ndembi, N., Hamers, R. L. & Marconi, V. C. Global epidemiology of drug resistance afer failure of WHO recommended frst-line regimens for adult HIV-1 infection: a multicenter retrospective cohort study. Te Lancet Infectious Diseases. 16, 565–575 (2016).

13. Rabanal, M., Ponce, N. M. A., Navarro, D. A., Gomez, R. M. & Strotz, C. A. Te system of fucoidans from the brown seaweed Dictyota dichotoma: Chemical analysis and antiviral activity. Carbohydrate Polymers. 101(0), 804–811 (2014).


Copyright  2020.  All rights reserved.  Infinitum Health, LLC.  *These statements have not been evaluated by the Food and Drug Administration (FDA) or Federal Trade Commission (FTC).  These products are not intended to diagnose, treat, cure or prevent any disease.  This web site (inclusive of blog articles, email marketing, labeling on products and any reference links) are not to be used as a substitute for medical advice, diagnosis or treatment of any health condition or problem. Users of this web site (inclusive of blog articles, email marketing, labeling on products and any reference links) should not rely on information provided for their own health problems.  Any questions regarding your own health should be addressed to your physician or other healthcare provider.  We provide the research and information and request customers to read through it thoroughly and educate themselves to aid in making an informed and safe decision to buy.   US Patents: 14-454548, 62006732, 89065289, 89078900

*If a purchase is made, implied consent is assumed and your email address will be added to our customer list.  Feel free to unsubscribe if you don't want discounts, updates, or research evidence.

Infinitum Health, LLC, 3820 W Happy Valley Rd Suite 141 No 419, Glendale, AZ 85310

(480) 371-6620)


  • Facebook Social Icon
  • Pinterest Social Icon
  • Twitter Social Icon
  • LinkedIn Social Icon
  • YouTube Social  Icon